
Patientory
Patientory is a technology company.
Financial History
Patientory has raised $2.0M across 1 funding round.
Frequently Asked Questions
How much funding has Patientory raised?
Patientory has raised $2.0M in total across 1 funding round.

Patientory is a technology company.
Patientory has raised $2.0M across 1 funding round.
Patientory has raised $2.0M in total across 1 funding round.
Patientory is a health-tech company headquartered in Atlanta, Georgia, that builds a blockchain-enabled platform for patients to own, control, and monetize their personal health data while enabling enterprises to access aggregated insights.[1][2][5] Its core products include a mobile app acting as a digital health wallet for actionable insights, personalized care plans (e.g., for diabetes, hypertension, heart health), and the enterprise tool Neith for analytics, AI-driven clinical trial recruitment, and population health management.[2][3][6] The platform solves siloed health data fragmentation across providers, improving interoperability, security via HIPAA-compliant PTOYMatrix blockchain, and outcomes through predictive analytics and rewards like $PTOY tokens for healthy behaviors.[1][2][5] Patientory serves individuals, health brokers, self-insured employers, payors, pharmaceuticals, FQHCs, and sports organizations, generating revenue via subscriptions and pharma contracts; by late 2023, it had 45,000+ subscribers, $4M+ in contracts, and data from 24,000+ health systems.[1][3]
Founded by Chrissa McFarlane, an entrepreneur with expertise in blockchain and health IT, Patientory emerged to address healthcare's data silos using blockchain for secure patient empowerment—initially pioneering as one of the first movers in Health IT blockchain applications.[2][3][5] McFarlane, CEO, has highlighted blockchain's potential for patient data security and access, stemming from industry challenges like fragmented records and inefficient transfers.[3][5] Early traction included partnerships with thousands of U.S. care providers, beta testing a clinical trial tracker that drew 2,000 users, and recognition as a World Economic Forum Technology Pioneer in 2021.[1][5][8] Key milestones: December 2023 partnership with Wharton’s Impact Venture Associates amid strong growth metrics.[1]
Patientory rides the convergence of blockchain, AI, and decentralized health data trends, capitalizing on post-pandemic demands for interoperability amid regulations like HIPAA and GDPR.[1][2][6] Timing aligns with rising AI health analytics (e.g., Google integrations) and Web3 adoption, where siloed data hinders ML applications—Patientory's PTOYMatrix unlocks this for global outcomes, especially in underserved areas via cost-reducing portability.[1][5][6] Market forces like exploding clinical trial needs and chronic disease prevalence favor it; as a first-mover, it influences Health IT by democratizing data ownership, boosting engagement, and enabling equitable access—pioneering blockchain's shift from crypto to real-world healthcare utility.[2][3][8]
Patientory is poised to scale via expanding PTOYMatrix partnerships, AI enhancements for precision care, and Web3 monetization amid blockchain health adoption. Trends like decentralized identity, regulatory pushes for data portability, and AI-driven trials will amplify growth, potentially evolving it into a dominant player in population health ecosystems. With proven traction, it could redefine patient empowerment, tying back to its mission of centralized, secure data at users' fingertips for optimized global health.
Patientory has raised $2.0M in total across 1 funding round.
Patientory's investors include Active Capital, Backstage Capital, Bedrock Capital, Bessemer Venture Partners, CapitalX, Color Capital, Craft Ventures, Cyphr VC, Lightspeed Venture Partners, LOI Venture, Long Journey Ventures, Paradox Capital.
Patientory has raised $2.0M across 1 funding round. Most recently, it raised $2.0M Seed in April 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 1, 2023 | $2.0M Seed | Active Capital, Backstage Capital, Bedrock Capital, Bessemer Venture Partners, CapitalX, Color Capital, Craft Ventures, Cyphr VC, Lightspeed Venture Partners, LOI Venture, Long Journey Ventures, Paradox Capital, Prototype Capital, Rising Tide Partners, SaaSholic Fund, Shaan's All Access Fund, The Club, The Hit Forge, Vibe Capital, Weekend Fund, Alex Lieberman, Anthony Pompliano, Ben Tossell, Chris Herd, Dharmesh Shah, Greg Isenberg, Immad Akhund, Jaime Schmidt, Julian Shapiro, Justin Welsh, Kyle York, Moshe Lifschitz, Musaab Hakami, Paul Yacoubian, Sahil Lavingia, Sam Parr, Zack Kanter |